Overview of Dr. Bartlett
Dr. Nancy Bartlett is an oncologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Siteman Cancer Center, Barnes-Jewish Hospital, and Barnes-Jewish West County Hospital. She received her medical degree from Washington University in St. Louis School of Medicine and has been in practice 31 years. Dr. Bartlett accepts several types of health insurance, listed below. She is one of 112 doctors at Barnes-Jewish Hospital and one of 41 doctors at Barnes-Jewish West County Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
4921 Parkview Pl
7th Floor
Saint Louis, MO 63110Fax(314) 361-3192- Is this information wrong?
Education & Training
- Stanford Health CareFellowship, Medical Oncology, 1990 - 1993
- University of California (San Francisco) School of MedicineInternship, Internal Medicine, 1986 - 1987
- Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
- MO State Medical License 1993 - 2023
- CA State Medical License 1988 - Present
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012
Clinical Trials
- Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma Start of enrollment: 1996 Apr 01
- Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma Start of enrollment: 1996 Nov 01
- Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma Start of enrollment: 1999 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.N Nora Bennani, Aung M Tun, Kenneth R Carson, Jessica L Geiger, Lauren S Maeda, Kerry J Savage, Jim Rose, Lauren Pinter-Brown, Matthew A Lunning, Jeremy S Abramson, Na...> ;Clinical lymphoma, myeloma & leukemia. 2022 May 1
- 2 citationsPhase I/Dose Expansion Trial of Brentuximab vedotin/Lenalidomide in Relapsed or Refractory Diffuse Large B-cell Lymphoma.Jeffrey P. Ward, Melissa M. Berrien-Elliott, Felicia Gomez, Jingqin Luo, Michelle Becker-Hapak, Amanda F. Cashen, Nina D. Wagner-Johnston, Kami J. Maddocks, Matthew Mo...> ;Blood. 2021 Nov 15
- 5 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, L. Elizabeth Budde, Paolo Caimi, Sven de V...> ;Journal of The National Comprehensive Cancer Network. 2021 Nov 1
- Join now to see all
Journal Articles
- CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin’s LymphomaMark P Chao, Sonali M Smith, Ranjana Advani, Ian Flinn, Ravindra Majeti, Nancy L Bartlett, Leslie Popplewell, Justin Kline, Nilanjan Ghosh, Ann LaCasce, The New England Journal of Medicine
- Rituximab with ABVD vs ABVD for Advanced Stage High-Risk Classical Hodgkin Lymphoma: A Randomized Phase II StudyFrancesco Turturro, Luis E Fayad, Anas Younes, Michelle Fanale, Yasuhiro Oki, Hun Ju Lee, Nancy L Bartlett, Haematologica
- Rituximab plus Lenalidomide in Advanced Untreated Follicular LymphomaIan W Flinn, Nancy L Bartlett, The New England Journal of Medicine
- Join now to see all
Abstracts/Posters
- North American Practice Patterns for PET-2 Positive Hodgkin LymphomaNancy L. Bartlett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- T-Cell Clonal Expansion and Activation Associated with Durable Clinical Response to Dual BTK and CDK4/6 Inhibitor Therapy in Mantle Cell LymphomaNancy L Bartlett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Composite Copy Number Variation in CDK4, CDKN2A and RB1 Predisposes Mantle Cell Lymphoma to Expansion of PD1+ Tumor Cells and Resistance to CDK4/6 Inhibitor Therapy as...Nancy L. Bartlett, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Lectures
- Managing cytokine release syndrome (CRS) and neurotoxicity with step-fractionated dosing of mosunetuzumab in relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (NHL).ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Brentuximab Vedotin with Chemotherapy for Stage 3/4 Classical Hodgkin Lymphoma (cHL): 4-Year Update of the Echelon-1 Study61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymph...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Adding Brentuximab Vedotin to Frontline R-CHOP Results in 80% Response Rate in Advanced DLBCLJune 26th, 2015
- Study Finds Standard R-CHOP Bests Dose-Adjusted EPOCH-R in DLBCLJuly 1st, 2019
- OncLive® to Host State of the Science Summit™ on Treatment of Hematologic MalignanciesNovember 5th, 2018
- Join now to see all
Grant Support
- Wumc Cancer And Leukemia Group BNational Cancer Institute2009–2012
- Data And Safety MonitoringNational Cancer Institute2010–2011
- Wumc-Cancer And Leukemia Group BNational Cancer Institute2003–2008
- Quality Assurance And Safety MonitoringNational Cancer Institute2004
- 24hr Infusion Of Hmr1275 In Fludarabine--B Cell LeukemiaNational Center For Research Resources2000–2002
- Wusm Cancer And Leukemia Group BNational Cancer Institute1998–2002
- Coadmin Rising Oral Gg918 Dose Levels (GH120918) W/ Doxorubicin In Cancer PTSNational Center For Research Resources1998–1999
Hospital Affiliations
- Siteman Cancer CenterSaint Louis, Missouri
- Barnes-Jewish HospitalSaint Louis, Missouri
- Barnes-Jewish West County HospitalSaint Louis, Missouri
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
BCBS Massachusetts Blue Care Elect PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Coventry Health Care PPO PlatinumCoventry Missouri - HMO/POS
First Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: